Loading...
Why tyrosine kinase inhibitor resistance is common in advanced gastrointestinal stromal tumors
Background: Most patients with advanced gastrointestinal stromal tumors (GIST) develop drug resistance to tyrosine kinase inhibitors (TKIs) within two years of starting therapy, whereas most chronic myeloid leukemia (CML) patients in chronic phase still exhibit disease control after a decade on ther...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
F1000Research
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3892920/ https://ncbi.nlm.nih.gov/pubmed/24555070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.2-152.v1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|